{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T21:03:47Z","timestamp":1779829427079,"version":"3.53.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.arth.2025.10.068","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:14:29Z","timestamp":1761959669000},"page":"1971-1976.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Bone Marrow Transplant on Total Joint Arthroplasty Outcomes in Patients Diagnosed With Multiple Myeloma"],"prefix":"10.1016","volume":"41","author":[{"given":"Randall R.","family":"Rainwater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P.","family":"Siebenmorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Mears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Stronach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Lowry","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0950-5227","authenticated-orcid":false,"given":"Jeffrey B.","family":"Stambough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2025.10.068_bib1","series-title":"Multiple myeloma","author":"Albagoush","year":"2023"},{"key":"10.1016\/j.arth.2025.10.068_bib2","series-title":"Plasma cell dyscrasias","first-page":"3","article-title":"MGUS and smoldering multiple myeloma: diagnosis and epidemiology","author":"Mateos","year":"2016"},{"key":"10.1016\/j.arth.2025.10.068_bib3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.arth.2025.10.068_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/bloodadvances.2016002493","article-title":"Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States","volume":"1","author":"Costa","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.arth.2025.10.068_bib5","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.OA.22.00112","article-title":"Projections and epidemiology of primary hip and knee arthroplasty in medicare patients to 2040-2060","volume":"8","author":"Shichman","year":"2023","journal-title":"JBJS Open Access"},{"key":"10.1016\/j.arth.2025.10.068_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/sci.2019.10.05","article-title":"Survival analysis of multiple myeloma patients after autologous stem cell transplantation","volume":"6","author":"Li","year":"2019","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.arth.2025.10.068_bib7","article-title":"The role of allogeneic stem cell transplantation in multiple myeloma: a systematic review of the literature","volume":"13","author":"Khorochkov","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.arth.2025.10.068_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3324\/haematol.2013.096149","article-title":"Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers","volume":"99","author":"Mohty","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.arth.2025.10.068_bib9","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma","volume":"376","author":"Attal","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.arth.2025.10.068_bib10","series-title":"Graft-Versus-Host disease","author":"Vaillant","year":"2024"},{"key":"10.1016\/j.arth.2025.10.068_bib11","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arth.2025.10.068_bib12","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1182\/blood-2016-09-737825","article-title":"Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide","volume":"129","author":"Kanakry","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.arth.2025.10.068_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcot.2019.07.018","article-title":"Complications of total joint arthroplasty in solid organ transplant patients versus a large control group","volume":"11","author":"Brown","year":"2020","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.arth.2025.10.068_bib14","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.arth.2025.01.008","article-title":"Survivorship and outcomes of hip arthroplasty for elective care versus fracture in patients who have solid organ transplant: Lung transplant patients Do worse","volume":"40","author":"Wininger","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.10.068_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.arth.2019.08.045","article-title":"Revision joint arthroplasty and renal transplant: a matched control cohort study","volume":"35","author":"Labaran","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.10.068_bib16","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.arth.2023.11.030","article-title":"Risk factors in patients who had prior renal or liver transplant undergoing primary total knee arthroplasty","volume":"39","author":"Mansour","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.10.068_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.artd.2024.101373","article-title":"Total joint arthroplasty is a viable treatment option for patients with osteonecrosis and osteoarthritis after bone marrow transplantation","volume":"27","author":"Chang","year":"2024","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2025.10.068_bib18","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.arth.2016.01.029","article-title":"Early postoperative outcomes after total joint arthroplasty in patients with multiple myeloma","volume":"31","author":"Menendez","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.10.068_bib19","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Journal of Clinical Oncology antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA Clinical Practice Guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arth.2025.10.068_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.artd.2020.04.002","article-title":"Total knee periprosthetic joint infection in the setting of hematologic malignancy: considerations for management","volume":"6","author":"Bloom","year":"2020","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2025.10.068_bib21","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.arth.2023.05.019","article-title":"Postoperative outcomes in total hip and total knee arthroplasty for patients who have multiple myeloma","volume":"38","author":"Salimy","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.10.068_bib22","series-title":"Transplant infections","first-page":"843","article-title":"Infection prevention and control issues after solid organ transplantation","author":"Banach","year":"2016"},{"key":"10.1016\/j.arth.2025.10.068_bib23","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1200\/JCO.2014.55.1028","article-title":"Multiple myeloma in the older adult: better prospects, more challenges","volume":"32","author":"Wildes","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arth.2025.10.068_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.arth.2025.10.068_bib25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/21505594.2016.1208866","article-title":"Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection","volume":"7","author":"Mehta","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.arth.2025.10.068_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: a population-based study","volume":"20","author":"Melton","year":"2005","journal-title":"J Bone Mineral Res"},{"key":"10.1016\/j.arth.2025.10.068_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41409-018-0264-8","article-title":"Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement","volume":"54","author":"Gonsalves","year":"2019","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.arth.2025.10.068_bib28","article-title":"Hospital readmission rates following primary total hip arthroplasty: present and future in sight","volume":"3","author":"Lamo-Espinosa","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.arth.2025.10.068_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.arth.2024.07.041","article-title":"Predictive modeling of medical and orthopaedic-related 90-Day-Readmissions following primary total knee arthroplasty","volume":"40","author":"Khan","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.10.068_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11999-013-3030-7","article-title":"What are the rates and causes of hospital readmission after total knee arthroplasty? Knee","volume":"472","author":"Schairer","year":"2014","journal-title":"Clin Orthopaedics Relat Res"},{"key":"10.1016\/j.arth.2025.10.068_bib31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.arth.2017.09.048","article-title":"Readmission, reoperation, and complications: total hip vs total knee arthroplasty","volume":"33","author":"George","year":"2018","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.10.068_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216935","article-title":"Immunosuppressive Agents\u2014Effects on the cardiovascular System and selected metabolic aspects: a review","volume":"12","author":"Opa\u0142ka","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.arth.2025.10.068_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2023.01.010","article-title":"Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C","volume":"223","author":"Ghansah","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.arth.2025.10.068_bib34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/bjh.16764","article-title":"The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: is it time for a paradigm shift?","volume":"191","author":"Kazandjian","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arth.2025.10.068_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2019.07.013","article-title":"The stimulation of thrombosis by hypoxia","volume":"181","author":"Gupta","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.arth.2025.10.068_bib36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3324\/haematol.2017.164012","article-title":"Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation","volume":"102","author":"Kekre","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.arth.2025.10.068_bib37","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3324\/haematol.2022.280893","article-title":"Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel","volume":"107","author":"De Stefano","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.arth.2025.10.068_bib38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.leu.2405062","article-title":"Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma","volume":"22","author":"Palumbo","year":"2008","journal-title":"Leukemia"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325013713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325013713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T20:26:45Z","timestamp":1779827205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540325013713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0883540325013713"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2025.10.068","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Bone Marrow Transplant on Total Joint Arthroplasty Outcomes in Patients Diagnosed With Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2025.10.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}